Skip Navigation


JAC Advance Access originally published online on March 13, 2008
Journal of Antimicrobial Chemotherapy 2008 61(5):976-994; doi:10.1093/jac/dkn096
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Data
Right arrow An erratum has been published
Right arrow An erratum has been published
Right arrow All Versions of this Article:
61/5/976    most recent
dkn096v2
dkn096v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Nathwani, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nathwani, D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Review

Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community

Dilip Nathwani1,*, Marina Morgan2, Robert G. Masterton3, Matthew Dryden4, Barry D. Cookson5, Gary French6, Deirdre Lewis on behalf of the British Society for Antimicrobial Chemotherapy Working Party on Community-onset MRSA Infections7

1 Infection Unit, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK 2 Royal Devon & Exeter NHS Foundation Trust, Exeter EX2 5DW, UK 3 Lothian University Hospitals NHS Trust, Edinburgh EH3 9YW, UK 4 Royal Hampshire County Hospital, Winchester SO22 5DG, UK 5 Laboratory of Healthcare-Associated Infection, HPA Centre for Infections, London 9W9 5HT, UK 6 St Thomas' Hospital, Kings' College, London SE1 7EH, UK 7 HPA Southwest, Stonehouse, Gloucester GL10 3RF, UK

* Corresponding author. Tel: +44-1382-660111; Fax: +44-1382-816178; E-mail: dilip.nathwani{at}nhs.net

These guidelines have been developed by a Working Party convened on behalf of the British Society for Antimicrobial Chemotherapy. Their aim is to provide general practitioners and other community- and hospital-based healthcare professionals with pragmatic advice about when to suspect MRSA infection in the community, when and what cultures should be performed and what should be the management options, including the need for hospitalization.

Keywords: community onset , case scenarios , MRSA infection , diagnosis , management


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Antimicrob ChemotherHome page
M. Dryden, K. Hand, P. Davey, and on behalf of the BSAC Council
Antibiotics for community-acquired pneumonia
J. Antimicrob. Chemother., December 1, 2009; 64(6): 1123 - 1125.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
G. D. Barlow and on behalf of the BSAC Council
Swine flu and antibiotics
J. Antimicrob. Chemother., November 1, 2009; 64(5): 889 - 894.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
S. Svetitsky, L. Leibovici, and M. Paul
Comparative Efficacy and Safety of Vancomycin versus Teicoplanin: Systematic Review and Meta-Analysis
Antimicrob. Agents Chemother., October 1, 2009; 53(10): 4069 - 4079.
[Abstract] [Full Text] [PDF]

Home page
 J Med MicrobiolHome page
N. Ahmad, I. N. Ruzan, M. K. Abd Ghani, A. Hussin, S. Nawi, M. N. Aziz, N. Maning, and V. L. K. Eow
Characteristics of community- and hospital-acquired meticillin-resistant Staphylococcus aureus strains carrying SCCmec type IV isolated in Malaysia
J. Med. Microbiol., September 1, 2009; 58(9): 1213 - 1218.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
F. K. Gould, R. Brindle, P. R. Chadwick, A. P. Fraise, S. Hill, D. Nathwani, G. L. Ridgway, M. J. Spry, R. E. Warren, and on behalf of the MRSA Working Party of the British
Guidelines (2008) for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the United Kingdom
J. Antimicrob. Chemother., May 1, 2009; 63(5): 849 - 861.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
R. A. Seaton
Daptomycin: rationale and role in the management of skin and soft tissue infections
J. Antimicrob. Chemother., November 1, 2008; 62(suppl_3): iii15 - iii23.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.